TR199701417T1 - Benzopiranlar - Google Patents

Benzopiranlar

Info

Publication number
TR199701417T1
TR199701417T1 TR97/01417T TR9701417T TR199701417T1 TR 199701417 T1 TR199701417 T1 TR 199701417T1 TR 97/01417 T TR97/01417 T TR 97/01417T TR 9701417 T TR9701417 T TR 9701417T TR 199701417 T1 TR199701417 T1 TR 199701417T1
Authority
TR
Turkey
Prior art keywords
opyrans
arylsulphonamido
brons
5alkyl
benzopyrans
Prior art date
Application number
TR97/01417T
Other languages
English (en)
Turkish (tr)
Inventor
W. Manley Paul
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199701417(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199701417T1 publication Critical patent/TR199701417T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR97/01417T 1995-05-24 1996-05-24 Benzopiranlar TR199701417T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
TR199701417T1 true TR199701417T1 (xx) 1998-02-21

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01417T TR199701417T1 (xx) 1995-05-24 1996-05-24 Benzopiranlar

Country Status (30)

Country Link
US (1) US5905156A (https=)
EP (1) EP0828733B1 (https=)
JP (1) JPH11505820A (https=)
KR (1) KR100437981B1 (https=)
CN (1) CN1077888C (https=)
AR (1) AR004489A1 (https=)
AT (1) ATE205204T1 (https=)
AU (1) AU703276B2 (https=)
BR (1) BR9609048A (https=)
CA (1) CA2217821C (https=)
CO (1) CO4700520A1 (https=)
CZ (1) CZ294474B6 (https=)
DE (1) DE69615019T2 (https=)
DK (1) DK0828733T3 (https=)
ES (1) ES2163634T3 (https=)
FI (1) FI973992A7 (https=)
GB (1) GB9510477D0 (https=)
HU (1) HU222772B1 (https=)
IL (1) IL118382A (https=)
MY (1) MY114924A (https=)
NO (1) NO314846B1 (https=)
NZ (1) NZ309765A (https=)
PL (1) PL184144B1 (https=)
PT (1) PT828733E (https=)
RU (1) RU2160735C2 (https=)
SK (1) SK283215B6 (https=)
TR (1) TR199701417T1 (https=)
TW (1) TW421646B (https=)
WO (1) WO1996037490A1 (https=)
ZA (1) ZA964209B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
KR101078357B1 (ko) * 2002-08-29 2011-10-31 닛산 가가쿠 고교 가부시키 가이샤 아미노벤조피란 화합물의 제조방법
US7098340B2 (en) 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(n-메틸치환술폰아미도)메틸-2h-1-벤조피란 유도체
CA2999769A1 (en) 2015-09-28 2017-04-06 Genentech, Inc. Therapeutic compounds and methods of use thereof
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) * 2017-03-24 2020-04-16 ジェネンテック, インコーポレイテッド ナトリウムチャネル阻害剤としての4−ピペリジン−n−(ピリミジン−4−イル)クロマン−7−スルホンアミド誘導体
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (https=) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
CN1185153A (zh) 1998-06-17
AR004489A1 (es) 1998-12-16
NZ309765A (en) 2000-01-28
DE69615019D1 (de) 2001-10-11
IL118382A (en) 2000-01-31
PL184144B1 (pl) 2002-09-30
CO4700520A1 (es) 1998-12-29
SK283215B6 (sk) 2003-03-04
CA2217821A1 (en) 1996-11-28
TW421646B (en) 2001-02-11
CZ368897A3 (cs) 1998-02-18
CZ294474B6 (cs) 2005-01-12
IL118382A0 (en) 1996-09-12
HUP9801751A2 (hu) 1999-06-28
NO314846B1 (no) 2003-06-02
KR19990021925A (ko) 1999-03-25
GB9510477D0 (en) 1995-07-19
NO975365D0 (no) 1997-11-21
HK1014137A1 (en) 1999-09-24
ATE205204T1 (de) 2001-09-15
DE69615019T2 (de) 2002-06-06
JPH11505820A (ja) 1999-05-25
MX9709004A (es) 1998-03-31
FI973992L (fi) 1997-12-09
SK157797A3 (en) 1998-05-06
EP0828733A1 (en) 1998-03-18
FI973992A7 (fi) 1997-12-09
CA2217821C (en) 2008-05-06
CN1077888C (zh) 2002-01-16
US5905156A (en) 1999-05-18
DK0828733T3 (da) 2001-12-17
BR9609048A (pt) 1999-02-23
ZA964209B (en) 1997-11-24
MY114924A (en) 2003-02-28
HUP9801751A3 (en) 1999-08-30
KR100437981B1 (ko) 2004-07-16
PT828733E (pt) 2002-02-28
ES2163634T3 (es) 2002-02-01
AU6000896A (en) 1996-12-11
FI973992A0 (fi) 1997-10-17
NO975365L (no) 1998-01-15
EP0828733B1 (en) 2001-09-05
RU2160735C2 (ru) 2000-12-20
HU222772B1 (hu) 2003-10-28
AU703276B2 (en) 1999-03-25
PL324042A1 (en) 1998-05-11
WO1996037490A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
TR199701417T1 (xx) Benzopiranlar
WO2002062295A3 (en) Pyridine-substituted benzanilides as potassium ion channel openers
AU2003303384A1 (en) Uses of mammalian cytokine; related reagents
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
BR0311443A (pt) Método e dispositivo para controlar farmacocinética de droga
ES2182906T3 (es) Grapa quirurgica helicoidal.
NO930738L (no) Nye cyklosporinger, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
AU2002228993A1 (en) Mycoplasma hyopneumoniae bacterin vaccine
GB2414183A (en) Methods and devices for therapeutic treatment cardiac and other pathologies
ES2110375T1 (es) Agente antiinflamatorio para uso externo.
IL158735A0 (en) Novel ligand for nicotinic acetylcholine receptors useful in therapy
DE69905170T2 (de) Thiazolopyrimidinderivate
UY27080A1 (es) Nuevas imidazotriazinonas sustituídas
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
DE69712900D1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
AU2002238427A1 (en) Radiotherapeutic apparatus comprising multileaf collimator
TR199900195T2 (xx) S�tmaya kar�� a�� kompozisyonu.
NO20044898L (no) Nye etonogestrel estere
ES2051733T3 (es) Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local.
AU2001287890A1 (en) Radiotherapy apparatus and collimator set therefor
CO5580812A2 (es) Absorbentes y sus usos
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
NL7801650A (nl) Nieuwe 1-/(diarylmethyl)-aminoalkyl/ piperidinen met neuroleptische werkzaamheid, alsmede thera- peutische preparaten, die deze nieuwe piperidi- nen als werkzame stof bevatten.
IL149722A0 (en) Device for radial in depth skin therapy
ES2152315T3 (es) Xamoneline tartrato.